Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
 29,150
 -150 (-0.51%)
  At close: Oct 30, 2025
Daihan Pharmaceutical Company Description
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea.
The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions.
Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.
Daihan Pharmaceutical Co.,Ltd.
  | Country | South Korea | 
| Founded | 1945 | 
| Industry | Pharmaceutical Preparations | 
| Employees | 553 | 
| CEO | Sungyoung Lee | 
Contact Details
| Address: 3, Seonyu-ro 45-gil Seoul, 07209 South Korea | |
| Phone | 82 2 2678 3911 | 
| Website | daihan.com | 
Stock Details
| Ticker Symbol | 023910 | 
| Exchange | KOSDAQ | 
| Stock Type | Common Stock | 
| Fiscal Year | January - December | 
| Reporting Currency | KRW | 
| SIC Code | 2834 | 
Key Executives
| Name | Position | 
|---|---|
| Sungyoung Lee | Chief Executive Officer |